Molecular Characterization of the Commonly Used Human Androgen Receptor Expression Vector, pSG5-AR

Prostate

Volumn 58, Issue 4, 2004, Pages 319-324

  Litvinov, Ivan V ^a   Chang, Chawnshang ^b   Isaacs, John T ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c 162B CRB ^*  (United States)

Author keywords

3 UTR; 5 UTR; Androgen receptor; CAG repeat; GGC repeat; pSG5 AR

Indexed keywords

ANDROGEN RECEPTOR; ANDROGEN RECEPTOR PSG5; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; EXPRESSION VECTOR; GENE MAPPING; GENE SEQUENCE; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; SEQUENCE ANALYSIS; TRINUCLEOTIDE REPEAT;

BASE SEQUENCE; DNA, COMPLEMENTARY; GENETIC VECTORS; HUMANS; PLASMIDS; RECEPTORS, ANDROGEN; RESTRICTION MAPPING; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEATS;

EID: 1542377565     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20027     Document Type: Article

References (26)

1. Chang CS, Kokontis J, Liao ST. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988;240:324-326.
2. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988;240:327-330.
3. Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS. Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 1989;86:9534-9538.
4. Litvinov IV, De Marzo AM, Isaacs JT. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 2003;88:2972-2982.
5. Faber PW, van Rooij HC, van der Korput HA, Baarends WM, Brinkmann AO, Grootegoed JA, Trapman J. Characterization of the human androgen receptor transcription unit. J Biol Chem 1991;266:10743-10749.
6. Martinez ED, Danielsen M. Loss of androgen receptor transcriptional activity at the G(1)/S transition. J Biol Chem 2002;277:29719-29729.
7. Yeap BB, Voon DC, Vivian JP, McCulloch RK, Thomson AM, Giles KM, Czyzyk-Krzeska MF, Furneaux H, Wilce MC, Wilce JA, Leedman PJ. Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3′-untranslated region of the androgen receptor messenger RNA. J Biol Chem 2002;277:27183-27192.
8. Mizokami A, Chang C. Induction of translation by the 5′ -untranslated region of human androgen receptor mRNA. J Biol Chem 1994;269:25655-25659.
9. Grossmann ME, Lindzey J, Kumar MV, Tindall DJ. The mouse androgen receptor is suppressed by the 5′-untranslated region of the gene. Mol Endocrinol 1994;8:448-455.
10. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 2000;9:267-274.
11. Beilin J, Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000;25:85-96.
12. Callewaert L, Christiaens V, Haelens A, Verrijdt G, Verhoeven G, Claessens F. Implications of a polyglutamine tract in the function of the human androgen receptor. Biochem Biophys Res Commun 2003;306:46-52.
13. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 1997;82:3777-3782.
14. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186.
15. Coetzee GA, Ross RK. Prostate cancer and the androgen receptor. J Natl Cancer Inst 1994;86:872-873.
16. Mononen N, Ikonen T, Autio V, Rokman A, Matikainen MP, Tammela TL, Kallioniemi OP, Koivisto PA, Schleutker J. Androgen receptor CAG polymorphism and prostate cancer risk. Hum Genet 2002;111:166-171.
17. Ferro P, Catalano MG, Dell'Eva R, Fortunati N, Pfeffer U. The androgen receptor CAG repeat: A modifier of carcinogenesis? Mol Cell Endocrinol 2002;193:9-20.
18. Yeh S, Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996;93:5517-5521.
19. Gao T, Marcelli M, McPhaul MJ. Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 1996;59:9-20.
20. Lumbroso R, Beitel LK, Vasiliou DM, Trifiro MA, Pinsky L. Codon-usage variants in the polymorphic (GGN)n trinucleotide repeat of the human androgen receptor gene. Hum Genet 1997;101:43-46.
21. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 2000;19:5406-5417.
22. Heisler LE, Evangelou A, Lew AM, Trachtenberg J, Elsholtz HP, Brown TJ. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol 1997;126:59-73.
23. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F, Keating A. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res 1993;53:1304-1311.
24. Nightingale J, Chaudhary KS, Abel PD, Stubbs AP, Romanska HM, Mitchell SE, Stamp GW, Lalani N. Ligand activation of the androgen receptor downregulates e-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells. Neoplasia 2003;5:347-361.
25. Davis R, Jia D, Cinar B, Sikka SC, Moparty K, Zhau HE, Chung LW, Agrawal KC, Abdel-Mageed A. Functional androgen receptor confers sensitization of androgen-independent prostate cancer cells to anticancer therapy via caspase activation. Biochem Biophys Res Commun 2003;309:937-945.
26. Sun M, Yang L, Feldman RI, Sun XM, Bhalla KN, Jove R, Nicosia SV. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J Biol Chem 2003;278:42992-43000.